Biomarkers for the Early Detection and Prognosis of Acute Kidney Injury

Clinical journal of the American Society of Nephrology: CJASN

Rakesh Malhotra¹ 

[1] *Division of Nephrology and Hypertension, Department of Medicine, University of California San Diego, San Diego, California;†Division of Nephrology and Hypertension, Department of Medicine, Vanderbilt University Medical center, Nashville, Tennessee

关键词: acute renal failure;    biomarkers;    acute kidney injury;    creatinine;    Early Diagnosis;    Prognosis;   

DOI  :  10.2215/CJN.01300216

学科分类：泌尿医学

来源: American Society of Nephrology

【 摘 要 】

AKI is an increasingly common disorder that is strongly linked to short- and long-term morbidity and mortality. Despite a growing heterogeneity in its causes, providing a timely and certain diagnosis of AKI remains challenging. In this review, we summarize the evolution of AKI biomarker studies over the past few years, focusing on two major areas of investigation: the early detection and prognosis of AKI. We highlight some of the lessons learned in conducting AKI biomarker studies, including ongoing attempts to address the limitations of creatinine as a reference standard and the recent shift toward evaluating the prognostic potential of these markers. Lastly, we suggest current gaps in knowledge and barriers that may be hindering their incorporation into care and a full ascertainment of their value.

【 授权许可】

CC BY